Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Neuroendocrine Tumors 394Multiple Endocrine Neoplasia Type 1 156Carcinoma, Neuroendocrine 123Thyroid Cancer, Papillary 118Pituitary Neoplasms 116Thyroid Neoplasms 100Pheochromocytoma 91Neoplasms 79Carcinoid Tumor 76Thyroid Carcinoma, Anaplastic 73Adrenocortical Carcinoma 73Paraganglioma 65Neoplasm Metastasis 56Adenocarcinoma, Follicular 53Carcinoma, Non-Small-Cell Lung 51Carcinoma, Medullary 50Insulinoma 49Pancreatic Neoplasms 47Adenoma, Islet Cell 47Colorectal Neoplasms 44Breast Neoplasms 44Small Cell Lung Carcinoma 42Sarcoma 42Gastro-enteropancreatic neuroendocrine tumor 42Carcinoma, Renal Cell 41Somatostatinoma 38Head and Neck Neoplasms 38Melanoma 37Lung Neoplasms 37Adrenal Gland Neoplasms 34

Interventions

Saline Solution 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Adrenal Insufficiency × Endocrine × Clear all
NCT04621565 2020-11-09

Hydrocortisone Use During Peri-operation for Pituitary Adenomas

Peking Union Medical College Hospital

Phase NA Unknown
436 enrolled
Endocrine

Adrenal Insufficiency, Pituitary Neoplasms

NCT03083834 2019-01-18

Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients

Bnai Zion Medical Center

Phase NA Unknown
50 enrolled
Endocrine

Adrenal Insufficiency, Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡